دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Cardiovascular diseases in pregnancy, congenital heart disease, and arrhythmias: lessons from epidemiology
Filippo Crea
doi : 10.1093/eurheartj/ehad084
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 699–702
Can three-dimensional echocardiography change the game for the pulmonary valve?
Tuğba Kemaloğlu Öz, Luigi Paolo Badano
doi : 10.1093/eurheartj/ehac772
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 703–705
Campaigners call for action on familial hypercholesterolaemia with the Prague Declaration
Judith Ozkan
doi : 10.1093/eurheartj/ehac655
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 706–708
Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease
Yaling Han
doi : 10.1093/eurheartj/ehac625
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 709–710,
Helicobacter pylori eradication as a gastroprotective strategy in elderly aspirin-treated subjects: established facts and unanswered questions
Giovanna Liuzzo, Carlo Patrono
doi : 10.1093/eurheartj/ehac808
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 711–712
Artificial intelligence to enhance clinical value across the spectrum of cardiovascular healthcare
Simrat K Gill, Andreas Karwath, Hae-Won Uh, Victor Roth Cardoso, Zhujie Gu, Andrey Barsky, Luke Slater, Animesh Acharjee, Jinming Duan, Lorenzo Dall'Olio, Said el Bouhaddani, Saisakul Chernbumroong, Mary Stanbury, Sandra Haynes, Folkert W Asselbergs, Diederick E Grobbee, Marinus J C Eijkemans, Georgios V Gkoutos, Dipak Kotecha, BigData@Heart Consortium and the cardAIc group
doi : 10.1093/eurheartj/ehac758
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 713–725
Artificial intelligence (AI) is increasingly being utilized in healthcare. This article provides clinicians and researchers with a step-wise foundation for high-value AI that can be applied to a variety of different data modalities.
Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010–19
Monil Majmundar, Rajkumar Doshi, Kunal N Patel, Harshvardhan Zala, Ashish Kumar, Ankur Kalra
doi : 10.1093/eurheartj/ehac669
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 726–737
Contemporary data on the prevalence, trends, and outcomes of cardiovascular diseases (CVDs) in pregnant patients are limited. This study aimed to analyse the prevalence, trends, and outcomes of CVD and their subtypes in hospitalized pregnant patients in the USA.
Time to counter rising cardiovascular disease during pregnancy
Martha Gulati, Anum Minhas
doi : 10.1093/eurheartj/ehac770
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 738–740
Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study
Mohamad El-Chouli, Alessandra Meddis, Daniel M Christensen, Thomas A Gerds, Thomas Sehested, Morten Malmborg, Matthew Phelps, Casper N Bang, Ole Ahlehoff, Christian Torp-Pedersen, Caroline Sindet-Pedersen, Jakob Raunsø, Lars Idorn, Gunnar Gislason
doi : 10.1093/eurheartj/ehac727
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 741–748
In a continuously ageing population of patients with congenital heart disease (CHD), understanding the long-term risk of morbidity is crucial. The aim of this study was to compare the lifetime risks of developing comorbidities in patients with simple CHD and matched controls.
Addressing comorbidities in simple congenital heart disease: a critical step to achieve optimal long-term outcomes
Pastora Gallego
doi : 10.1093/eurheartj/ehac819
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 749–751
Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry
Saranda Haxha, Andrim Halili, Morten Malmborg, Ulrik Pedersen-Bjergaard, Berit T Philbert, Tommi B Lindhardt, Soeren Hoejberg, Anne-Marie Schjerning, Martin H Ruwald, Gunnar H Gislason, Christian Torp-Pedersen, Casper N Bang
doi : 10.1093/eurheartj/ehac662
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 752–761
The present study aimed to determine the association between Type 2 diabetes mellitus (T2DM) and third-degree (complete) atrioventricular block.
Type 2 diabetes mellitus association with atrioventricular block
Moshe Rav Acha, Michael Glikson
doi : 10.1093/eurheartj/ehac755
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 762–764
Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study
Jason G Andrade, Marc W Deyell, Laurent Macle, Jonathan S Steinberg, Taya V Glotzer, Nathaniel M Hawkins, Paul Khairy, Martin Aguilar
doi : 10.1093/eurheartj/ehac692
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 765–776
Atrial tachyarrhythmia recurrence ≥30 s remains the primary endpoint of clinical trials; however, this definition has not been correlated with clinical outcomes or pathophysiological processes. This study sought to determine the atrial tachyarrhythmia duration and burden associated with meaningful clinical outcomes.
Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good
Ahmed M Al-Kaisey, Jonathan M Kalman
doi : 10.1093/eurheartj/ehac736
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Pages 777–779
A rare case of a dorsal mass caused by descending thoracic aortic dissection
Ningshuai Ma, Ling Li, Xiaoqing Tang
doi : 10.1093/eurheartj/ehac674
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Page 780
Fatty infiltration of inferolateral left ventricular wall in Fabry disease
Gilles Soulat, Jean Nicolas Dacher
doi : 10.1093/eurheartj/ehac719
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Page 781
Plaque rupture after coronary CT angiography
Kana Hojo, Kenichiro Otsuka, Noriaki Kasayuki
doi : 10.1093/eurheartj/ehac743
European Heart Journal, Volume 44, Issue 9, 1 March 2023, Page 782,
